Viewing Study NCT05613894


Ignite Creation Date: 2025-12-25 @ 1:28 AM
Ignite Modification Date: 2025-12-27 @ 11:57 PM
Study NCT ID: NCT05613894
Status: RECRUITING
Last Update Posted: 2025-10-31
First Post: 2022-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Dose-Escalation Study of Cabozantinib in Combination With Lutetium-177 (177Lu)-PSMA-617 in Patients With Metastatic Castration-Resistant Prostate Cancer
Sponsor: University of Utah
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module